ALEXIS DIAL: Open Payments
NPI 1649891920 · NEPTUNE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 13 payments from 7 companies in 2025. Trend: 2023 $40 · 2024 $263 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| Chiesi USA, Inc. | 4 | $130 |
| Merck Sharp & Dohme LLC | 3 | $55 |
| ABBVIE INC. | 2 | $37 |
| Pulmonx Corporation | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
| Theratechnologies Inc. | 1 | $16 |
| Melinta Therapeutics, LLC | 1 | $15 |
Products named: CLEVIPREX, ZERBAXA, PIFELTRO, EMBLAVEO, AVYCAZ, CHARTIS CATHETER, JARDIANCE, EGRIFTA.
Industry payments across NJ — which companies pay providers there.
